Overview
Next Generation Pneumococcal Vaccines: What You Need to Know
Live symposium
Registration is closed for this activity.
What’s new with pneumococcal vaccines? In 2021, two exciting, next-generation pneumococcal vaccines have become available. This satellite symposium will feature leading experts, Michael Hogue, PharmD, FAPhA, FNAP, Donald Middleton, MD, and Margot Savoy, MD, MPH, FAAFP, who will outline the characteristics and latest recommendations with these novel vaccines. Additional topics to be discussed include how to overcome present barriers with vaccine uptake (particularly amidst the ongoing COVID-19 pandemic), and the key serotypes most responsible for invasive pneumococcal disease. Don’t throw away your shot! Attend this engaging activity.
This activity is intended for internal medicine physicians and other clinicians who manage adult patients for whom pneumococcal vaccination is recommended.
HCPs lack knowledge of the shifting epidemiology and serotype distribution of invasive pneumococcal disease. Clinicians also require up-to-date knowledge of ACIP recommendations for pneumococcal immunization and best practices in introducing CDC recommendations into practice. Finally, clinicians require strategies to engage and guide patients through shared decision-making and identify missed opportunities for vaccination. This educational initiative provides a means for clinicians to overcome these knowledge and competency gaps.
Upon completion of this activity, participants will be able to:
• Explain the rationale behind the development of next-generation pneumococcal vaccines
• Identify highest-risk groups who should receive a pneumococcal vaccine
• Formulate strategies to engage patients and encourage pneumococcal vaccine uptake
• Outline the latest ACIP recommendations for pneumococcal vaccination
• Explain the rationale behind the development of next-generation pneumococcal vaccines
• Identify highest-risk groups who should receive a pneumococcal vaccine
• Formulate strategies to engage patients and encourage pneumococcal vaccine uptake
• Outline the latest ACIP recommendations for pneumococcal vaccination
Room 190 in the McCormick Place Convention Center
2301 S King Dr
Chicago, IL 60616 USA
Click here to view location map
2301 S King Dr
Chicago, IL 60616 USA
Click here to view location map
12:00 PM- Lunch and Registration
12:15 PM- Introductions and Certification Information
12:15 PM – 12:25 PM- Adult Vaccinations: Current Affairs
12:25 PM – 12:50 PM- Next-Generation Pneumococcal Vaccines
12:50 PM – 1:10 PM- Strategies to Facilitate Adult Immunization Against Pneumococcal Disease
1:10 PM – 1:15 PM- Questions and Answers
12:15 PM- Introductions and Certification Information
12:15 PM – 12:25 PM- Adult Vaccinations: Current Affairs
12:25 PM – 12:50 PM- Next-Generation Pneumococcal Vaccines
12:50 PM – 1:10 PM- Strategies to Facilitate Adult Immunization Against Pneumococcal Disease
1:10 PM – 1:15 PM- Questions and Answers
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
This activity is supported through an Independent Medical Education grant from Merck & Co., Inc..
Michael Hogue, PharmD, FAPhA, FNAP
Dean and Professor
Loma Linda University - School of Pharmacy
Professor of Preventive Medicine, School of Medicine
Director, Center for Interprofessional Education & Practice
Loma Linda University
Loma Linda, CA
Dean and Professor
Loma Linda University - School of Pharmacy
Professor of Preventive Medicine, School of Medicine
Director, Center for Interprofessional Education & Practice
Loma Linda University
Loma Linda, CA
Donald Middleton, MD
Professor of Family Medicine
University of Pittsburgh School of Medicine
UPMC St. Margaret
Pittsburgh, PA
Margot Savoy, MD, MPH, FAAFP
Associate Professor of Family & Community Medicine
Associate Professor of Urban Bioethics & Population Health
Lewis Katz School of Medicine at Temple University
Philadelphia, PA
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Michael Hogue, PharmD, FAPhA, FNAP
No financial relationships to disclose
Donald B. Middleton, MD
Advisor or Review Panel member: Pfizer Inc.
Consultant (occasional): Pfizer Inc.
Speaker Bureau: Pfizer Inc
Margot Savoy, MD, MPH, FAAFP
Advisory Panel: Eisai
Independent Contractor: Merck & Co., Inc.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Please note: Presentation slides may not reflect printed slides.
*This lunch symposium is not part of the official Internal Medicine Meeting 2022 Education Program.
To receive credit, participants are required to participate in the live activity and complete the pretest, posttest, and evaluation and submit on-site. A certificate will be emailed to participants within 6 weeks. There is no fee to participate in the activity or for the generation of the certificate.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
